Working Opportunity Fund is the famous VC, which was founded in 2003. The venture was found in North America in Canada. The leading representative office of defined VC is situated in the Vancouver.
Considering the real fund results, this VC is 6 percentage points less often commits exit comparing to other organizations. This Working Opportunity Fund works on 0 percentage points less the average amount of lead investments comparing to the other organizations. The top activity for fund was in 2003. The common things for fund are deals in the range of 10 - 50 millions dollars. The higher amount of exits for fund were in 2015. The fund is generally included in less than 2 deals every year.
For fund there is a match between the country of its foundation and the country of its the most frequent investments - Canada. Besides, a startup requires to be at the age of 2-3 years to receive the investment from the fund. Among the various public portfolio startups of the fund, we may underline MSI Methylation Sciences, AppNeta, Teradici Among the most popular fund investment industries, there are Business Intelligence, Health Care. The fund has exact preference in a number of founders of portfolio startups.
The typical case for the fund is to invest in rounds with 4-5 participants. Despite the Working Opportunity Fund, startups are often financed by Skypoint Capital, GrowthWorks Capital, Alta Berkeley Venture Partners. The meaningful sponsors for the fund in investment in the same round are Yaletown Partners, Ventures West, TELUS Ventures. In the next rounds fund is usually obtained by Yaletown Partners, OVP Venture Partners, GrowthWorks Capital.
Funds with similar focus
Fund Name | Location |
Alante Capital | New York, New York, United States |
Atinum Partners | Seoul, Seoul-t'ukpyolsi, South Korea |
Bailibowen | Beijing, Beijing, China |
Blockwall Management | Frankfurt, Germany, Hessen |
Brand New Matter | Connecticut, Darien, United States |
Cattles Invoice Finance | Abingdon, Oxfordshire, United Kingdom |
Coldstream | Bellevue, United States, Washington |
Crevisse | Seoul, Seoul-t'ukpyolsi, South Korea |
DC Capital Partners | Alexandria, United States, Virginia |
LongueVue Capital | Louisiana, Metairie, United States |
Milestone Capital Advisors | India, Maharashtra, Mumbai |
Morningside Ventures | - |
Partners Innovation Fund | Boston, Massachusetts, United States |
Renren Games | Baoshan, China, Shanghai |
Tencent Industry Win-Win Fund | China, Guangdong, Shenzhen |
The Walden Group | New York, Tarrytown, United States |
Xinweiyang Equity Investment Management | China, Shanghai |
Xinyu Canjin Touzi Hehuo Qiye (Youxian Hehuo) | China, Jiangxi, Xinyu |
Yosemite | - |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
MSI Methylation Sciences | $15M | 29 Sep 2011 | Burnaby, British Columbia, Canada | ||
Teradici | $17M | 07 Apr 2009 | Burnaby, British Columbia, Canada | ||
Teradici | $18M | 14 Feb 2007 | Burnaby, British Columbia, Canada | ||
GenoLogics | $5M | 03 Feb 2005 | Victoria, British Columbia | ||
AppNeta | $7M | 01 Oct 2003 | Boston, Massachusetts, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
MSI Methylation Sciences | $15M | 29 Sep 2011 | Burnaby, British Columbia, Canada | ||
Teradici | $17M | 07 Apr 2009 | Burnaby, British Columbia, Canada | ||
Teradici | $18M | 14 Feb 2007 | Burnaby, British Columbia, Canada | ||
GenoLogics | $5M | 03 Feb 2005 | Victoria, British Columbia | ||
AppNeta | $7M | 01 Oct 2003 | Boston, Massachusetts, United States |